Search

Search Constraints

You searched for: Author/Creator Grünig, Ekkehard

Search Results

1. Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension. Issue 1 (December 2016)

2. Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. (1st June 2015)

3. Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. (June 2015)

4. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Issue 5 (23rd November 2017)

5. An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. (20th January 2022)

6. Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study. (December 2020)

7. Assessment of the REPLACE study composite endpoint in riociguat‐treated patients in the PATENT study. (1st December 2020)

8. Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension. (February 2021)

9. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Issue 2 (February 2016)

10. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Issue 10 (6th January 2017)